CSBR vs LOW · P/E 16, rev $56.9M vs P/E 18, rev $86.29B
Champions Oncology Inc (CSBR) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the CSBR and LOW stock pages for the full models.
Not investment advice.